Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 201-250 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07210411
Acute and Chronic Repercussion of Spinal Cord Stimulation After Spinal Cord Injury
NARecruiting
80 participants
Started: Nov 1, 2025 · Completed: Apr 1, 2031
1 condition1 sponsor1 location
NCT07216898
Clean Beauty in Newark, NJ
N/ARecruiting
120 participants
Started: Nov 1, 2025 · Completed: Nov 1, 2026
2 conditions2 sponsors1 location
NCT05956821
Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
PHASE1/PHASE2Recruiting
20 participants
Started: Nov 1, 2025 · Completed: Dec 1, 2029
8 conditions1 sponsor1 location
NCT07187388
Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.
NARecruiting
10 participants
Started: Nov 1, 2025 · Completed: Aug 13, 2026
3 conditions1 sponsor1 location
NCT06675123
Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma
PHASE1Recruiting
10 participants
Started: Nov 1, 2025 · Completed: Mar 8, 2028
2 conditions2 sponsors1 location
NCT07202117
PLLA and CaHA-R for Aesthetic Rejuvenation
PHASE4Recruiting
45 participants
Started: Nov 1, 2025 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT07147816
Cervical Transcutaneous SCS for TBI
NARecruiting
80 participants
Started: Nov 1, 2025 · Completed: Nov 1, 2029
2 conditions2 sponsors1 location
NCT06492954
Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
PHASE1Recruiting
12 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2027
2 conditions2 sponsors1 location
NCT07179055
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
PHASE2Recruiting
160 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2026
1 condition1 sponsor5 locations
NCT06949410
HER2 Vaccine for Locally Advanced Breast Cancer
PHASE1Recruiting
36 participants
Started: Oct 31, 2025 · Completed: Mar 31, 2030
2 conditions1 sponsor1 location
NCT06517121
tDCS in People With Subthreshold Depression
NARecruiting
204 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2027
1 condition3 sponsors1 location
NCT07189897
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
PHASE4Recruiting
76 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT07212244
Analysis of Clinical Outcomes in Patients Undergoing Magnetic Resonance-Guided Focused Ultrasound for Medication-Refractory Tremor
N/ARecruiting
240 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2032
2 conditions1 sponsor1 location
NCT06956690
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
PHASE1/PHASE2Recruiting
180 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2027
3 conditions1 sponsor6 locations
NCT07212803
Effects of Energy Drinks on Cardiovascular Endpoints
PHASE4Recruiting
3 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT07192133
Evaluation of CT-XPI
PHASE2Recruiting
30 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2026
2 conditions1 sponsor1 location
NCT06579469
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
N/ARecruiting
100 participants
Started: Oct 31, 2025 · Completed: Mar 31, 2029
3 conditions2 sponsors1 location
NCT07039084
Using a Speech-Generating Device to Support Communication in Childhood Dementia
NARecruiting
38 participants
Started: Oct 31, 2025 · Completed: May 31, 2027
4 conditions1 sponsor1 location
NCT07090460
Pulmonary Overdistension Assessment With Electrical Impedance Tomography in Patients With Acute Respiratory Distress Syndrom in Prone Position.
N/ARecruiting
30 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06528691
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
PHASE2Recruiting
52 participants
Started: Oct 31, 2025 · Completed: Nov 30, 2032
2 conditions2 sponsors1 location
NCT05237687
The Role of Sirolimus in Preventing Functional Decline in Older Adults
PHASE2Recruiting
10 participants
Started: Oct 31, 2025 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT04563520
SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
PHASE3Recruiting
5 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2026
1 condition2 sponsors2 locations
NCT07192107
A Study of MHB042C in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
200 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2029
1 condition1 sponsor1 location
NCT07170748
Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
N/ARecruiting
2,950 participants
Started: Oct 31, 2025 · Completed: Mar 31, 2026
6 conditions4 sponsors2 locations
NCT07192120
A Study of MHB048C in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
200 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2029
2 conditions1 sponsor1 location
NCT07095504
A Study of Cardiac Rehabilitation Intervention to Improve Cardiovascular Health and Outcomes
NARecruiting
15 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2027
1 condition1 sponsor3 locations
NCT06751238
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
PHASE1Recruiting
20 participants
Started: Oct 31, 2025 · Completed: Dec 1, 2032
1 condition1 sponsor3 locations
NCT07011420
Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control
NARecruiting
32 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2026
6 conditions1 sponsor2 locations
NCT06889168
Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
PHASE1Recruiting
20 participants
Started: Oct 31, 2025 · Completed: Mar 31, 2027
2 conditions3 sponsors2 locations
NCT06921317
GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma
PHASE1/PHASE2Recruiting
12 participants
Started: Oct 31, 2025 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT06798623
Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells
PHASE1Recruiting
15 participants
Started: Oct 31, 2025 · Completed: Mar 31, 2030
1 condition1 sponsor1 location
NCT07118852
Developing Remote Human Milk Collection as a Novel Technique for Transcriptome Sequencing
NARecruiting
50 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT07023614
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
PHASE2Recruiting
165 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT07127978
A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
N/ARecruiting
300 participants
Started: Oct 31, 2025 · Completed: Jul 30, 2030
1 condition1 sponsor2 locations
NCT07217379
The DART DELIVER-02 Study
PHASE1Recruiting
24 participants
Started: Oct 31, 2025 · Completed: Feb 28, 2027
1 condition5 sponsors3 locations
NCT06991270
OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma
NARecruiting
25 participants
Started: Oct 31, 2025 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT07174687
SGLT2 Inhibitors in Geographic Atrophy
PHASE2Recruiting
70 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2027
5 conditions1 sponsor1 location
NCT07059494
Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
PHASE4Recruiting
40 participants
Started: Oct 31, 2025 · Completed: Aug 1, 2028
1 condition2 sponsors1 location
NCT06880731
Training Inner Speech in Children With Developmental Language Disorder
NARecruiting
75 participants
Started: Oct 31, 2025 · Completed: Mar 31, 2028
1 condition2 sponsors1 location
NCT06938412
Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation
NARecruiting
120 participants
Started: Oct 31, 2025 · Completed: Mar 31, 2027
3 conditions2 sponsors1 location
NCT07083596
Efficacy of LcS-Fermented Milk on Constipation-Related Symptoms in Filipino Adults
NARecruiting
60 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2026
2 conditions2 sponsors1 location
NCT06358040
Opioid Dispenser for Microdiscectomy/Laminectomy
NARecruiting
30 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT06861088
The Effect of Kinisoquin on Thromboembolic Events in Patients With Metastatic Pancreatic Cancer
PHASE3Recruiting
480 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2029
2 conditions1 sponsor1 location
NCT07084909
Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCC
PHASE2/PHASE3Recruiting
286 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2027
1 condition1 sponsor2 locations
NCT07205328
A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke
PHASE2Recruiting
360 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT07205289
Serum Collection Study for Assay Development
PHASE1Recruiting
12 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT07160608
Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
PHASE2Recruiting
75 participants
Started: Oct 31, 2025 · Completed: Feb 14, 2028
1 condition1 sponsor75 locations
NCT07194044
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
PHASE1Recruiting
15 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2030
1 condition2 sponsors17 locations
NCT07200375
An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma
N/ARecruiting
300 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2030
1 condition1 sponsor1 location
NCT07218822
Impact of Pistachio Consumption on Sleep.
NARecruiting
28 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2027
1 condition2 sponsors1 location